mesalamine has been researched along with Hypertension in 3 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At least 1% of patients with Crohn's disease develop amyloidosis." | 2.45 | Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. ( Basturk, T; Kusaslan, R; Ozagari, A; Ozturk, T; Unsal, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mei, X | 1 |
| Mell, B | 1 |
| Manandhar, I | 1 |
| Aryal, S | 1 |
| Tummala, R | 1 |
| Kyoung, J | 1 |
| Yang, T | 1 |
| Joe, B | 1 |
| Basturk, T | 1 |
| Ozagari, A | 1 |
| Ozturk, T | 1 |
| Kusaslan, R | 1 |
| Unsal, A | 1 |
| Lachaine, J | 1 |
| Yen, L | 1 |
| Beauchemin, C | 1 |
| Hodgkins, P | 1 |
1 review available for mesalamine and Hypertension
| Article | Year |
|---|---|
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Crohn Disease; Dise | 2009 |
2 other studies available for mesalamine and Hypertension
| Article | Year |
|---|---|
Repurposing a Drug Targeting Inflammatory Bowel Disease for Lowering Hypertension.
Topics: Animals; Drug Delivery Systems; Drug Repositioning; Dysbiosis; Hypertension; Inflammatory Bowel Dise | 2022 |
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Canada; Coliti | 2013 |